With the recent introduction of PolyHeal, TEVA UK has entered the Wound Care sector. Developed for use on hard-to-heal wounds, PolyHeal has been clinically shown to result in a significant reduction in wound size after just one month’s treatment – even in wounds with exposed bones and tendons.
It consists of negatively charged polystyrene microspheres, suspended in a nutrient medium, which interact with cellular components within the wound bed to activate the inflammatory and proliferation phases of wound healing.1,2 It also has clinically proven results in treating hard-to-heal wounds across a variety of wound types:3
• Granulation coverage in 63% of wounds after four weeks.
• 40% wound size reduction after four weeks.
• 36% of wounds closed within 12 weeks.
The results of two open-label studies of chronic wounds of multiple aetiologies – including venous, diabetic and ischaemic ulcers – showed that 87% of patients treated with PolyHeal achieved significant wound improvement after four weeks of treatment. Furthermore, all exposed bones and tendons were covered after four weeks.
References
1 Dulbecco’s Modified Eagle’s Medium (DMEM).
2 PolyHeal. Instructions For Use.
3 Zeilig G. et al. Study to evaluate PolyHeal-1 in treatment of recalcitrant wounds. DOF November 2010.
